Guggenheim Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX), Top Pick
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| (NASDAQ: MLTX) | Delayed: 11.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.56 | 52 Week High | $ | |||
| Open | $11.56 | 52 Week Low | $ | |||
| Day High | $11.56 | P/E | N/A | |||
| Day Low | $11.56 | EPS | $ | |||
| Volume | 1,130 | |||||
